Puerto Rico Technology Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Puerto Rico Technology Today.

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Press releases published on December 9, 2025

December 9, 2025

Opus Genetics Announces Positive Recommendation from Independent Data Monitoring Committee for Phase 1/2 Trial in Best Disease

GlobeNewswire

December 9, 2025

SailPoint Announces Fiscal Third Quarter 2026 Results

GlobeNewswire

December 9, 2025

Lantronix to Launch New Edge AI Solutions at CES 2026

GlobeNewswire

December 9, 2025

Fennec Pharmaceuticals Announces Investigator-Sponsored Trial to Be Conducted by City of Hope in Metastatic Testicular Germ Cell Tumors

GlobeNewswire

December 9, 2025

Transpire Bio Manufacturing Facility Receives the Establishment Inspection Report Following a Pre-Approval Inspection by the U.S. FDA

GlobeNewswire

$Senti Bio Announces Updated SENTI-202 Clinical Data from Ongoing Phase 1 Trial in Relapsed or Refractory Acute Myeloid Leukemia Patients, Demonstrating Deep, MRD Negative, Durable Complete Remissions and a Favorable Safety Profile$

December 9, 2025

Senti Bio Announces Updated SENTI-202 Clinical Data from Ongoing Phase 1 Trial in Relapsed or Refractory Acute Myeloid Leukemia Patients, Demonstrating Deep, MRD Negative, Durable Complete Remissions and a Favorable Safety Profile

GlobeNewswire

$Senti Bio Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for SENTI-202 in the Treatment of Adults with Relapsed or Refractory Acute Myeloid Leukemia$

December 9, 2025

Senti Bio Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for SENTI-202 in the Treatment of Adults with Relapsed or Refractory Acute Myeloid Leukemia

GlobeNewswire

TransAlta Signs Long-Term Agreement for 700 MW at Centralia Facility Enabling Coal to Natural Gas Conversion

December 9, 2025

Atos Drives Saudi Vision 2030 forward with leading sports and digital technologies at the second edition of World Football Summit in Riyadh

GlobeNewswire

Exclaimer on path to $100m ARR as organizations strengthen email governance and compliance controls

December 9, 2025

Actimed Therapeutics to Highlight Advancing Clinical Pipeline with New Data Presentations at 18th Annual Conference on Sarcopenia, Cachexia, and Wasting Disorders

GlobeNewswire

Puerto Rico Technology Today: Press Releases

October 2025

November 2025

December 2025

Press releases published on December 9, 2025

Opus Genetics Announces Positive Recommendation from Independent Data Monitoring Committee for Phase 1/2 Trial in Best Disease

SailPoint Announces Fiscal Third Quarter 2026 Results

Lantronix to Launch New Edge AI Solutions at CES 2026

Fennec Pharmaceuticals Announces Investigator-Sponsored Trial to Be Conducted by City of Hope in Metastatic Testicular Germ Cell Tumors

Transpire Bio Manufacturing Facility Receives the Establishment Inspection Report Following a Pre-Approval Inspection by the U.S. FDA

Senti Bio Announces Updated SENTI-202 Clinical Data from Ongoing Phase 1 Trial in Relapsed or Refractory Acute Myeloid Leukemia Patients, Demonstrating Deep, MRD Negative, Durable Complete Remissions and a Favorable Safety Profile

Senti Bio Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for SENTI-202 in the Treatment of Adults with Relapsed or Refractory Acute Myeloid Leukemia

TransAlta Signs Long-Term Agreement for 700 MW at Centralia Facility Enabling Coal to Natural Gas Conversion

Abpro Granted Nasdaq Listing Extension to Pursue Compliance and Strategic Objectives

Descartes Announces TSX Acceptance of Normal Course Issuer Bid

OBOOK Holdings Inc. (OWLS) Collaborates with Visa to Launch OwlPay Cash App for Remittances

Terns Announces Proposed Public Offering

SEON Joins Elite Group of AWS Partners with Three Earned Competencies

Atos Drives Saudi Vision 2030 forward with leading sports and digital technologies at the second edition of World Football Summit in Riyadh

Exclaimer on path to $100m ARR as organizations strengthen email governance and compliance controls

Insider Becomes Insider One to Make Marketing and Customer Engagement Teams Unstoppable

Lucidworks Cyber 5 Data Highlights Mobile Dominance and the Shift to Natural-Language Commerce

Vocalbeats Singapore Completes latest 2025 ISO Surveillance Audit — Reinforcing Foundations for Vocalbeats.AI

HDFC ERGO Shares Post-Pandemic Insights on Health Insurance: Global Lessons for Coverage and Risk

Actimed Therapeutics to Highlight Advancing Clinical Pipeline with New Data Presentations at 18th Annual Conference on Sarcopenia, Cachexia, and Wasting Disorders